Isolating sooner might have avoided first lockdown, Hunt says
The UK should have prepared to test and isolate more, the ex-health secretary tells the Covid inquiry.
Similar Posts
Disposable vapes to be banned over fears for children's health
Rishi Sunak announces the plan saying “we must act” to tackle a rise in vaping among children.
Business | Fitness - Gym | Health | Nutrition Life | Sports | Technology | Uncategorized
The Rise of Wearable Fitness Tech: Are You Keeping Up?
Fitness has come a long way from notepads and stopwatch timers. In today’s world, wearable fitness technology is redefining how we approach health, exercise, and everyday habits. Whether you’re a serious athlete or someone simply trying to walk more, wearables are changing the game—and if you haven’t jumped on the bandwagon yet, it’s worth asking:…
Enlarged prostate searches surge after King’s diagnosis
He added it would also alleviate stigma surrounding the condition, explaining that prostate problems have traditionally had a “perception of being something you don’t want to talk about” and “actually to be able to talk about it is a good thing, not least because the whole stack of things that we can do”.
Cameroon starts world-first malaria mass vaccine rollout
It becomes the first nation in the world to roll out a universal anti-malaria jab for infants.
Do you need a prostate check? King Charles III raises awareness of common men’s health condition
Even kings have prostate problems. King Charles III was admitted on Friday to The London Clinic, a private hospital, where he underwent a scheduled procedure due to an enlarged prostate, Buckingham Palace confirmed. The treatment was successful and the king is “doing quite well,” a royal source told Fox News Digital. The palace emphasized that…
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…